Affect lability and Ideational apraxia

Summary:

Ideational apraxia is reported only by a few people with Affect lability.

The study analyzes which people have Ideational apraxia with Affect lability. It is created by eHealthMe based on 1 person who has Ideational apraxia and Affect lability from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 29, 2023

1 person who has Affect Lability and Ideational Apraxia is studied.

What is Affect lability?

Affect lability (emotional incontinence) is found to be associated with 1,275 drugs and 747 conditions by eHealthMe.

What is Ideational apraxia?

Ideational apraxia (neurological disorder -difficulty with actions requiring planning) is found to be associated with 1,015 drugs and 839 conditions by eHealthMe.

Number of Ideational apraxia in Affect lability reports submitted per year:

Would you have Ideational apraxia when you have Affect lability?

Gender of people who have Affect Lability and experienced Ideational Apraxia *:

female: 0.0 %
male: 100 %

Age of people who have Affect Lability and experienced Ideational Apraxia *:

Common drugs taken by these people *:

Zoloft: 1 person, 100.00%
Valproic Acid: 1 person, 100.00%
Gabapentin: 1 person, 100.00%
Clonazepam: 1 person, 100.00%

Common symptoms for these people *:

Stress And Anxiety: 1 person, 100.00%
Pressure Ulcer: 1 person, 100.00%
Catatonia (unresponsive to external stimuli): 1 person, 100.00%
Bruxism (habitual grinding of the teeth, typically during sleep): 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ideational apraxia?

Check whether Ideational apraxia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Affect lability (12,349 reports)
Ideational apraxia (1,718 reports)

COVID vaccines that are related to Ideational apraxia:

How the study uses the data?

The study is based on Ideational apraxia and Affect lability, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.